• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弓形虫疫苗:现状、挑战与未来方向。

Vaccines against Toxoplasma gondii: status, challenges and future directions.

机构信息

Department of Parasitology, Shandong University School of Medicine, Jinan, Shandong, China.

出版信息

Hum Vaccin Immunother. 2012 Sep;8(9):1305-8. doi: 10.4161/hv.21006. Epub 2012 Aug 21.

DOI:10.4161/hv.21006
PMID:22906945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3579912/
Abstract

Toxoplasma gondii is a ubiquitous protozoan parasite that can infect a wide range of animals including humans. This single known species in the genus Toxoplasma is considered as one of the most successful eukaryotic pathogens which is of major medical and veterinary importance. Effective vaccines may contribute toward preventing and controlling the spread of toxoplasmosis. The present communication addresses the current status of development of vaccines against T. gondii. Further discussion is made on the difficulties along with challenges, such as vaccine construct, mode of vaccine administration and standardization of immunization evaluation. Finally suggestions are made on possible directions for future research on the development of vaccines against T. gondii.

摘要

刚地弓形虫是一种广泛存在的原生动物寄生虫,可感染包括人类在内的多种动物。在刚地弓形虫属中,这唯一已知的物种被认为是最成功的真核病原体之一,具有重要的医学和兽医意义。有效的疫苗可能有助于预防和控制弓形体病的传播。本通讯介绍了目前针对刚地弓形虫的疫苗开发状况。进一步讨论了疫苗构建、疫苗接种方式和免疫评估标准化等方面的困难和挑战。最后,就刚地弓形虫疫苗开发的未来研究方向提出了建议。

相似文献

1
Vaccines against Toxoplasma gondii: status, challenges and future directions.弓形虫疫苗:现状、挑战与未来方向。
Hum Vaccin Immunother. 2012 Sep;8(9):1305-8. doi: 10.4161/hv.21006. Epub 2012 Aug 21.
2
Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.用编码刚地弓形虫超氧化物歧化酶(TgSOD)的DNA疫苗进行免疫接种可诱导BALB/c小鼠对急性弓形虫病产生部分免疫保护。
BMC Infect Dis. 2017 Jun 7;17(1):403. doi: 10.1186/s12879-017-2507-5.
3
IL-17 and IL-22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB/c mice.DNA 疫苗编码 ROP13 诱导产生的 IL-17 和 IL-22 可保护 BALB/c 小鼠抵抗弓形虫感染。
J Cell Physiol. 2019 Jul;234(7):10782-10788. doi: 10.1002/jcp.27747. Epub 2018 Nov 22.
4
Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.刚地弓形虫:用编码SAG1、GRA2、GRA7和ROP16的T细胞和B细胞表位的DNA疫苗进行接种可引发小鼠对急性弓形虫病的保护作用。
Vaccine. 2015 Nov 27;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. Epub 2015 Oct 27.
5
Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice.含刚地弓形虫棒状体蛋白13的病毒样颗粒疫苗诱导小鼠对刚地弓形虫ME49感染产生保护作用。
Korean J Parasitol. 2019 Oct;57(5):543-547. doi: 10.3347/kjp.2019.57.5.543. Epub 2019 Oct 31.
6
Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.评价编码弓形虫表面抗原 1(SAG1)和 14-3-3 蛋白的 DNA 疫苗在 BALB/c 小鼠中诱导的保护性免疫应答。
Parasit Vectors. 2012 Nov 26;5:273. doi: 10.1186/1756-3305-5-273.
7
Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives.抗弓形虫疫苗的研究进展:挑战、机遇与展望。
Trends Parasitol. 2019 Mar;35(3):239-253. doi: 10.1016/j.pt.2019.01.005. Epub 2019 Feb 1.
8
Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.白细胞介素7和15与DNA疫苗联合使用可提高抗弓形虫的保护性免疫力。
Exp Parasitol. 2016 Mar;162:18-23. doi: 10.1016/j.exppara.2015.12.013. Epub 2015 Dec 17.
9
Yeast Shells Encapsulating Adjuvant AS04 as an Antigen Delivery System for a Novel Vaccine against .酵母壳包裹佐剂 AS04 作为一种新型疫苗的抗原传递系统,用于预防 。
ACS Appl Mater Interfaces. 2021 Sep 1;13(34):40415-40428. doi: 10.1021/acsami.1c12366. Epub 2021 Aug 17.
10
Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii.新型表达GRA14的抗弓形虫DNA疫苗诱导BALB/c小鼠免疫反应的评估
Parasite Immunol. 2017 Apr;39(4). doi: 10.1111/pim.12419.

引用本文的文献

1
Review of Toxoplasmosis: What We Still Need to Do.弓形虫病综述:我们仍需开展的工作
Vet Sci. 2025 Aug 18;12(8):772. doi: 10.3390/vetsci12080772.
2
Research on inner membrane complex protein 1: a novel nanovaccines against Toxoplasma gondii.内膜复合蛋白1的研究:一种新型抗弓形虫纳米疫苗
BMC Vet Res. 2025 Aug 23;21(1):521. doi: 10.1186/s12917-025-04961-z.
3
The Development of TIM-Barrel Based Multi-Epitope Protein for Serological Detection in Cats.用于猫血清学检测的基于TIM桶的多表位蛋白的开发
Animals (Basel). 2025 Jun 26;15(13):1893. doi: 10.3390/ani15131893.
4
among pregnant women attending antenatal care in a district hospital in Ghana.在加纳一家地区医院接受产前护理的孕妇中。
Public Health Chall. 2023 May 25;2(2):e82. doi: 10.1002/puh2.82. eCollection 2023 Jun.
5
Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice.针对 CST1 抗原的异源免疫比 ROP18 更能在小鼠中提供更好的保护。
Nanomedicine (Lond). 2024;19(29):2437-2446. doi: 10.1080/17435889.2024.2403333. Epub 2024 Sep 25.
6
The Search for Drugs Derived from Natural Products for Infection Treatment in the Last 20 Years - A Systematic Review.过去 20 年中从天然产物寻找抗感染治疗药物的研究进展——系统性综述。
Curr Top Med Chem. 2024;24(22):1960-1999. doi: 10.2174/0115680266299409240606062235.
7
Effective factors in the pathogenesis of .……发病机制中的有效因素。 你提供的原文不完整,“of”后面缺少具体内容。
Heliyon. 2024 May 19;10(10):e31558. doi: 10.1016/j.heliyon.2024.e31558. eCollection 2024 May 30.
8
Q fever and toxoplasmosis in South African livestock and wildlife: a retrospective study on seropositivity, sporadic abortion, and stillbirth cases in livestock caused by Coxiella burnetii.南非家畜和野生动物中的 Q 热和弓形体病:对贝氏柯克斯体引起家畜血清阳性、散发性流产和死产病例的回顾性研究。
BMC Vet Res. 2023 Sep 21;19(1):168. doi: 10.1186/s12917-023-03645-w.
9
Metallic Nanoparticles and Core-Shell Nanosystems in the Treatment, Diagnosis, and Prevention of Parasitic Diseases.金属纳米颗粒与核壳纳米系统在寄生虫病治疗、诊断及预防中的应用
Pathogens. 2023 Jun 17;12(6):838. doi: 10.3390/pathogens12060838.
10
Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein.表达刚地弓形虫囊壁蛋白的病毒样颗粒诱导的保护性黏膜和系统免疫。
PLoS One. 2023 Apr 27;18(4):e0283928. doi: 10.1371/journal.pone.0283928. eCollection 2023.

本文引用的文献

1
Foodborne toxoplasmosis.食源性弓形虫病。
Clin Infect Dis. 2012 Sep;55(6):845-51. doi: 10.1093/cid/cis508. Epub 2012 May 22.
2
Technologies for enhanced efficacy of DNA vaccines.增强 DNA 疫苗效力的技术。
Expert Rev Vaccines. 2012 Feb;11(2):189-209. doi: 10.1586/erv.11.188.
3
Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.新型基因佐剂重组 DNA 疫苗诱导的弓形虫保护性免疫应答。
Vaccine. 2012 Feb 27;30(10):1800-6. doi: 10.1016/j.vaccine.2012.01.004. Epub 2012 Jan 10.
4
Immunological mechanisms of vaccination.疫苗接种的免疫学机制。
Nat Immunol. 2011 Jun;12(6):509-17. doi: 10.1038/ni.2039.
5
Congenital toxoplasmosis treatment.先天性弓形虫病的治疗。
Eur Rev Med Pharmacol Sci. 2011 Feb;15(2):193-8.
6
TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants.TLR、NLR 激动剂和其他免疫调节剂作为传染病疫苗佐剂。
Curr Infect Dis Rep. 2010 Jan;12(1):4-12. doi: 10.1007/s11908-009-0080-9.
7
DNA vaccines: an historical perspective and view to the future.DNA 疫苗:历史透视与未来展望。
Immunol Rev. 2011 Jan;239(1):62-84. doi: 10.1111/j.1600-065X.2010.00980.x.
8
Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection.DNA 疫苗的生物安全性:新一代 DNA 载体和注射后质粒命运的现有知识。
Vaccine. 2010 May 21;28(23):3888-95. doi: 10.1016/j.vaccine.2010.03.040. Epub 2010 Apr 4.
9
History of the discovery of the life cycle of Toxoplasma gondii.刚地弓形虫生活史的发现史。
Int J Parasitol. 2009 Jul 1;39(8):877-82. doi: 10.1016/j.ijpara.2009.01.005.
10
Toxoplasma gondii proteomics.弓形虫蛋白质组学
Expert Rev Proteomics. 2009 Jun;6(3):303-13. doi: 10.1586/epr.09.16.